Indian Bank makes a corporate announcement

Indian Bank’s latest reported Tier-1 capital adequacy ratio was 15.18% as of 30 September 2026. CET1 was also 15.18%, while total CRAR was 16.21%, including 1.03% of Tier II capital. ^[1]

The ₹5,000 crore equity raise appears to be proactive growth capital rather than a response to an immediate capital shortfall:

• Management’s latest formal FY27 guidance was for 13–14% advances growth, revised upward from 11–13%; Q2 advances had already grown 16.39% YoY, partly helped by FCNR(B)-linked lending. ^[2]
• The AGM resolution authorises raising up to ₹5,000 crore through QIP, FPO, rights issue or a combination, with proceeds explicitly intended to strengthen RBI capital-adequacy compliance and provide growth capital. ^[3]
• Management described the existing 16.21% total CRAR as comfortable and expected retained profits to lift it to approximately 17–17.5% by March, before considering any additional Tier-2 issuance. ^[4]

Mechanical capital impact: As of September, Tier-1 capital was ₹73,704 Cr and total RWA was ₹4,85,556 Cr. ^[1] If the entire ₹5,000 Cr were issued and recognised as Tier-1 capital, with RWA unchanged, it would add approximately 1.0 percentage point to the Tier-1 ratio, taking it from 15.18% to roughly 16.2%. This is an illustrative calculation, not management guidance.

Against the 13–14% internal credit-growth target, the raise provides useful absorption capacity: assuming RWA expanded at the same rate as advances and no intervening profit accretion, the current Tier-1 ratio would mechanically fall to roughly 13.3–13.4%; including the full equity raise, it would remain around 14.2–14.3%. This is only a proxy because RWA growth depends on portfolio mix and risk weights, not advances growth one-for-one.

Regulatory interpretation: the cited disclosures do not quantify the applicable RBI minimum plus capital-conservation or other regulatory buffers, so the exact surplus above the regulatory requirement cannot be calculated. The evidence supports viewing the raise as a buffer-preservation and growth-enablement measure, not as capital required merely to restore compliance.

The current same-period ratio is 2.6% of deposits, but the exact share of total liabilities cannot be confirmed from the Q2 balance-sheet data cited. Indian Bank reported fresh FCNR(B) mobilisation of ₹22,486 Cr as of 30 September 2026, against total deposits of ₹8,74,036 Cr; the derived ratio is 2.6% of deposits. ^{[5] [6]} The disclosed plan was actually USD1.5–2.0 billion through FCNR(B), including ECB, rather than a separately identified USD1.5 billion FCNR-only tranche. ^[7]

Funding-cost implication

Management does not expect this funding to materially reduce the overall cost of funds. It compared the expected funding cost with deposit funding of around 6.0–6.5% and said the overall funding cost may not decline significantly. ^[7] The strategic benefit is therefore more about replacing expensive or less attractive domestic term funding than generating a structural cost advantage: bulk deposits declined by about ₹10,000 Cr, while retail-term-deposit mobilisation was deliberately moderated. ^[8]

For context, the bank’s Q2 FY27 reported standalone cost of funds was 4.9%. ^[9] The FCNR inflow should not be read as an automatic reduction in this ratio because the bank said the funds were already deployed rather than held as surplus liquidity. ^[8]

NIM sensitivity

There is no quantified basis-point impact attributed specifically to the USD1.5 billion tranche. The direction depends on deployment:

• FCNR-linked loans were offered at preferential rates, with customers borrowing up to 90–96% of the deposit value; this makes the incremental international book potentially less NIM-accretive than the domestic book. ^[8]
• Management acknowledged that growth in the international book could weigh on NIM. ^[8]
• Nevertheless, the CEO still expected overall NIM to expand by roughly 5–6 bps in the following quarter after adjusting for FCNR-linked loans, deposit tightening and rate changes. ^[10]

Analyst read: the tranche increases NIM sensitivity to asset-liability mix and loan pricing, but management views the effect as manageable. It is broadly NIM-neutral to mildly dilutive if deployed at preferential loan rates; substitution away from costly bulk deposits can offset that pressure.